We provide you with 20 years of free, institutional-grade data for IMGN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of IMGN. Explore the full financial landscape of IMGN stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2023-11-02 | 855654 | IMGN | 10-Q | Url |
2023-07-31 | 855654 | IMGN | 10-Q | Url |
2023-04-28 | 855654 | IMGN | 10-Q | Url |
2023-03-01 | 855654 | IMGN | 10-K | Url |
2022-11-04 | 855654 | IMGN | 10-Q | Url |
2022-08-01 | 855654 | IMGN | 10-Q | Url |
2022-05-06 | 855654 | IMGN | 10-Q | Url |
2022-02-28 | 855654 | IMGN | 10-K | Url |
2021-10-29 | 855654 | IMGN | 10-Q | Url |
2021-07-30 | 855654 | IMGN | 10-Q | Url |
2021-05-10 | 855654 | IMGN | 10-Q | Url |
2021-03-01 | 855654 | IMGN | 10-K | Url |
2020-11-06 | 855654 | IMGN | 10-Q | Url |
2020-08-05 | 855654 | IMGN | 10-Q | Url |
2020-05-05 | 855654 | IMGN | 10-Q | Url |
2020-03-11 | 855654 | IMGN | 10-K | Url |
2019-11-05 | 855654 | IMGN | 10-Q | Url |
2019-08-07 | 855654 | IMGN | 10-Q | Url |
2019-05-07 | 855654 | IMGN | 10-Q | Url |
2019-03-01 | 855654 | IMGN | 10-K | Url |
2018-11-02 | 855654 | IMGN | 10-Q | Url |
2018-08-03 | 855654 | IMGN | 10-Q | Url |
2018-05-09 | 855654 | IMGN | 10-Q | Url |
2018-03-07 | 855654 | IMGN | 10-K | Url |
2017-11-09 | 855654 | IMGN | 10-Q | Url |
2017-08-04 | 855654 | IMGN | 10-Q | Url |
2017-05-05 | 855654 | IMGN | 10-Q | Url |
2016-11-04 | 855654 | IMGN | 10-Q | Url |
2016-08-25 | 855654 | IMGN | 10-K | Url |
2016-05-04 | 855654 | IMGN | 10-Q | Url |
2016-02-04 | 855654 | IMGN | 10-Q | Url |
2015-10-30 | 855654 | IMGN | 10-Q | Url |
2015-08-27 | 855654 | IMGN | 10-K | Url |
2015-05-08 | 855654 | IMGN | 10-Q | Url |
2015-02-05 | 855654 | IMGN | 10-Q | Url |
2014-10-30 | 855654 | IMGN | 10-Q | Url |
2014-08-28 | 855654 | IMGN | 10-K | Url |
2014-05-02 | 855654 | IMGN | 10-Q | Url |
2014-02-05 | 855654 | IMGN | 10-Q | Url |
2013-10-29 | 855654 | IMGN | 10-Q | Url |
2013-08-29 | 855654 | IMGN | 10-K | Url |
2013-05-06 | 855654 | IMGN | 10-Q | Url |
2013-01-30 | 855654 | IMGN | 10-Q | Url |
2012-10-31 | 855654 | IMGN | 10-Q | Url |
2012-08-29 | 855654 | IMGN | 10-K | Url |
2012-05-10 | 855654 | IMGN | 10-Q | Url |
2012-01-31 | 855654 | IMGN | 10-Q | Url |
2011-10-31 | 855654 | IMGN | 10-Q | Url |
2011-08-29 | 855654 | IMGN | 10-K | Url |
2011-05-05 | 855654 | IMGN | 10-Q | Url |
2011-02-08 | 855654 | IMGN | 10-Q | Url |
2010-10-29 | 855654 | IMGN | 10-Q | Url |
2010-08-27 | 855654 | IMGN | 10-K | Url |
2010-04-30 | 855654 | IMGN | 10-Q | Url |
2010-01-29 | 855654 | IMGN | 10-Q | Url |
2009-11-04 | 855654 | IMGN | 10-Q | Url |
2009-08-28 | 855654 | IMGN | 10-K | Url |
2009-05-07 | 855654 | IMGN | 10-Q | Url |
2009-02-06 | 855654 | IMGN | 10-Q | Url |
2008-10-31 | 855654 | IMGN | 10-Q | Url |
2008-09-02 | 855654 | IMGN | 10-K | Url |
2008-05-09 | 855654 | IMGN | 10-Q | Url |
2008-02-07 | 855654 | IMGN | 10-Q | Url |
2007-11-07 | 855654 | IMGN | 10-Q | Url |
2007-08-30 | 855654 | IMGN | 10-K | Url |
2007-05-09 | 855654 | IMGN | 10-Q | Url |
2007-02-08 | 855654 | IMGN | 10-Q | Url |
2006-11-03 | 855654 | IMGN | 10-Q | Url |
2006-08-28 | 855654 | IMGN | 10-K | Url |
2006-05-05 | 855654 | IMGN | 10-Q | Url |
2006-02-09 | 855654 | IMGN | 10-Q | Url |
2005-11-08 | 855654 | IMGN | 10-Q | Url |
2005-08-29 | 855654 | IMGN | 10-K | Url |
2005-05-06 | 855654 | IMGN | 10-Q | Url |
2005-02-09 | 855654 | IMGN | 10-Q | Url |
2004-11-09 | 855654 | IMGN | 10-Q | Url |
2004-08-20 | 855654 | IMGN | 10-K | Url |
2004-05-14 | 855654 | IMGN | 10-Q | Url |
2004-02-13 | 855654 | IMGN | 10-Q | Url |
2003-11-14 | 855654 | IMGN | 10-Q | Url |
2003-09-26 | 855654 | IMGN | 10-K | Url |
2003-05-13 | 855654 | IMGN | 10-Q | Url |
2003-02-12 | 855654 | IMGN | 10-Q | Url |
2002-11-12 | 855654 | IMGN | 10-Q | Url |
2002-09-20 | 855654 | IMGN | 10-K | Url |
2002-05-13 | 855654 | IMGN | 10-Q | Url |
2002-02-14 | 855654 | IMGN | 10-Q | Url |
2001-11-14 | 855654 | IMGN | 10-Q | Url |
2001-09-28 | 855654 | IMGN | 10-K | Url |
2001-05-15 | 855654 | IMGN | 10-Q | Url |
2001-02-14 | 855654 | IMGN | 10-Q | Url |
2000-10-27 | 855654 | IMGN | 10-Q | Url |
2000-05-12 | 855654 | IMGN | 10-Q | Url |
2000-02-10 | 855654 | IMGN | 10-Q | Url |
1999-11-04 | 855654 | IMGN | 10-Q | Url |
1999-05-11 | 855654 | IMGN | 10-Q | Url |
1999-02-16 | 855654 | IMGN | 10-Q | Url |
1998-11-12 | 855654 | IMGN | 10-Q | Url |
1998-05-14 | 855654 | IMGN | 10-Q | Url |
1998-02-17 | 855654 | IMGN | 10-Q | Url |
1997-11-14 | 855654 | IMGN | 10-Q | Url |
1997-05-15 | 855654 | IMGN | 10-Q | Url |
1997-02-14 | 855654 | IMGN | 10-Q | Url |
1996-11-08 | 855654 | IMGN | 10-Q | Url |
1996-09-12 | 855654 | IMGN | 10-K | Url |
1996-05-10 | 855654 | IMGN | 10-Q | Url |
1996-02-14 | 855654 | IMGN | 10-Q | Url |
1995-11-13 | 855654 | IMGN | 10-Q | Url |
1995-09-28 | 855654 | IMGN | 10-K | Url |
1995-05-15 | 855654 | IMGN | 10-Q | Url |
ImmunoGen, Inc(NASDAQ:IMGN)


ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ov...
Website: http://www.immunogen.com
Founded: 1981
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about IMGN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.